No Data
No Data
Haoyuan Pharmaceutical (688131.SH) has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds.
Hao Yuan Pharmaceuticals (688131.SH) announced that on September 21, 2024, the company received the notice issued by the China Securities Regulatory Commission...
Earnings Tell The Story For Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131) As Its Stock Soars 27%
There May Be Some Bright Spots In Shanghai Haoyuan Chemexpress' (SHSE:688131) Earnings
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Largest Shareholders Are Private Companies Who Were Rewarded as Market Cap Surged CN¥855m Last Week
Shanghai Haoyuan Pharmaceutical Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Shanghai Haoyuan Pharmaceutical Co., Ltd.
No Data
No Data